Provided by Tiger Trade Technology Pte. Ltd.

XTL Biopharmaceuticals

2.46
-0.0100-0.40%
Volume:3.55K
Turnover:8.83K
Market Cap:5.82M
PE:-0.72
High:2.49
Open:2.49
Low:2.46
Close:2.47
52wk High:10.28
52wk Low:2.12
Shares:2.37M
Float Shares:1.29M
Volume Ratio:0.97
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4144
EPS(LYR):-1.1996
ROE:-577.13%
ROA:-240.56%
PB:-123.82
PE(LYR):-2.05

Loading ...

XTL Biopharmaceuticals trading halted, news pending

TIPRANKS
·
Mar 25

XTL Biopharmaceuticals to Change ADS Ratio

MT Newswires Live
·
Mar 21

XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026

TIPRANKS
·
Mar 21

Beyond Air announces termination of NeuroNOS agreement with XTL

TIPRANKS
·
Mar 10

XTL Biopharmaceuticals Faces Nasdaq Delisting After “Public Shell” Determination

TIPRANKS
·
Feb 28

XTL Biopharmaceuticals gets delisting letter from Nasdaq, to request hearing

TIPRANKS
·
Feb 28

XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing

GlobeNewswire
·
Feb 28

XTL Biopharmaceuticals Advances NeuroNOS Acquisition and Plans $2 Million Private Placement to Address Nasdaq Equity Deficiency

TIPRANKS
·
Jan 28

XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure

TIPRANKS
·
Jan 24

XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance

TIPRANKS
·
Jan 24

XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency

GlobeNewswire
·
Jan 24

ADRs Hold Steady; XTL Biopharmaceuticals Ltd. Climbs 57%

Dow Jones
·
Jan 14

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:49 AM

Reuters
·
Jan 13

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

GlobeNewswire
·
Jan 13

XTL Biopharmaceuticals Moves to Acquire NeuroNOS Stake from Beyond Air and Plans $2 Million Private Placement

TIPRANKS
·
Jan 13

ADRs Close Lower; XTL Biopharmaceuticals Ltd. Declines 16%

Dow Jones
·
Oct 10, 2025

Why Are Pharmaceutical Stocks XBIO, UPC, XTLB, & ACXP Up Today?

TIPRANKS
·
Oct 08, 2025